BioSpace News Archive

NeuClone Pharmaceuticals Ltd (NeuClone), a clinical-stage biopharmaceutical company developing high-quality biosimilar products, today disclosed two additional biosimilars in active development. The products are biosimilar candidates referencing Opdivo ® (nivolumab) and Keytruda ® (pembrolizumab). These biosimilars reference two antibody products that bl

INSIGHTEC®, a global medical technology innovator of incisionless surgery, today announced that it has received national reimbursement from the Japanese Ministry of Health, Labour and Welfare (MHLW) for treating Parkinson’s Disease.

NeuroMetrix, Inc. (Nasdaq: NURO) today reported the publication of a large study demonstrating that DPNCheck effectively determines the severity of diabetic peripheral neuropathy (DPN).

Magnolia Medical Technologies, Inc. today announced the launch of Mission to ZERO, a nationwide initiative to create greater awareness of the patient safety and antibiotic-associated risks caused by false-positive diagnostic test results for sepsis.

HX Global, the US division of leading international health and security provider Healix International, has announced plans to integrate with SAP® Concur® solutions. SAP Concur is the world’s leading brand for travel, expense and invoice management solutions.

Hansa Biopharma (“Hansa”), the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced updated guidance regarding its ongong and planned clinical trial program ahead of Management’s participation at upcoming investor conferences in September.

Baylis Medical announced today the first clinical use of the VersaCross Steerable Access Solution, performed at the University of California, San Francisco (UCSF).

Artio Medical, Inc. (Artio), a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced it has named Paul Muller to serve as Chief

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today announced that members of management will participate at the Morgan Stanley Global Healthcare Conference held on September 15, 2020. The presentation will begin at 4:15 PM Eastern Time and a live webcast will be accessible through the Investor Relations section of the Company’s website at https://investors.amneal.com . A replay of the webcast will be post

The National Pharmaceutical Council (NPC) today announced the appointment of Robert Dubois, MD, PhD, as its interim president and CEO